RSS Feeds
Elevated Serum Amylase Levels after Seizures
- W. Robert Graham, MD;
- Yair Lotan, MS; and
- Todd Painton, MS
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
A 65-year-old man was brought to our emergency department after a seizure. The patient was lethargic and confused when he arrived. The medication he had been prescribed, Dilantin (Parke-Davis, Morris Plains, New Jersey), was not present in his blood. Results of physical examination of the patient's abdomen were normal. His serum amylase level was 9.19 µkat/L (normal, 0.57 to 2.03 µkat/L). This elevation prompted physicians to do computed tomography of the abdomen. No abnormality was detected in the pancreas. The patient was admitted to the hospital for observation. His mental status became normal, he ate, and he had no abdominal pain. His serum amylase level the next day was 3.78 µkat/L; the patient felt well and was discharged.
We reviewed the charts of patients who were known to have had a generalized tonic-clonic seizure shortly before admission or during their hospital stay. We excluded those with evidence of pancreatitis, renal failure, or alcohol abuse. All charts that were reviewed had to have recorded an amylase level. Forty-one charts were reviewed, and 41 were randomly chosen to serve as controls. The serum amylase level was found to be elevated in 29 of the 41 (71%) patients who had had generalized tonic-clonic seizures but in only 4 (10%) controls.
In our hospital, measurement of the amylase level is part of our routine serum chemistry evaluations. For some time, one of us has seen that amylase levels are often elevated after a generalized seizure. Our chart review seems to support that observation. The source of this elevation is not clear but may be salivary. We have seen cases in which such patients had extensive and negative results of abdominal evaluations, such as the computed tomography of the abdomen in the patient we initially described. Knowing that amylase levels may increase after a seizure may save the patient the risk and expense of extensive abdominal evaluations.
W. Robert Graham, MD
Yair Lotan, MS
Todd Painton, MS
Baylor College of Medicine; Houston, TX 77030
- Copyright ©2004 by the American College of Physicians
